Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma
- PMID: 15361502
- PMCID: PMC1774221
- DOI: 10.1136/gut.2003.033324
Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma
Abstract
Background: Identification of risk factors for the development of hepatocellular carcinoma (HCC) is important for HCC surveillance in chronic hepatitis B virus (HBV) infection. Our aim was to study the independent risk factors and effect of HBV genotypes on HCC development in a prospective longitudinal cohort of chronic hepatitis B patients.
Patients and methods: Chronic hepatitis B patients recruited since 1997 were prospectively followed up for the development of HCC. HCC was diagnosed by a combination of alpha fetoprotein, imaging, and histology. Liver cirrhosis was defined as ultrasonic features of cirrhosis together with hypersplenism, ascites, varices, and/or encephalopathy.
Results: In total, 426 patients were followed up for 1664 person years; median 225 (range 12-295) weeks. Forty nine (11%) patients had underlying clinical liver cirrhosis. A total of 242 (57%) and 179 (42%) patients had HBV genotypes C and B, respectively. Twenty five patients developed HCC in a median follow up of 121 (range 14-236) weeks. The overall incidence of HCC was 1502 cases per 100 000 person years. On multivariate analysis, clinical liver cirrhosis and HBV genotype C infection were independently associated with HCC development, with an adjusted relative risk of 10.24 (95% confidence interval (CI) 4.39-23.89; p<0.001) and 2.84 (95% CI 1.05-7.72; p = 0.040), respectively. Patient age, sex, hepatitis B e antigen (HBeAg) status, alanine aminotransferase (ALT) levels, and basal core promoter mutations did not predict HCC development. Patients infected with HBV genotype C tended to have persistently positive HBeAg or fluctuating HBeAg status and higher ALT levels during the follow up period.
Conclusion: Genotype C HBV infection is an independent risk factor for HCC development in addition to liver cirrhosis.
Figures


Similar articles
-
Long-term follow-up of children with postnatal immunoprophylaxis failure who were infected with hepatitis B virus surface antigen gene mutant.J Infect Dis. 2013 Apr;207(7):1047-57. doi: 10.1093/infdis/jis943. Epub 2013 Jan 8. J Infect Dis. 2013. PMID: 23300165
-
Significance of hepatitis B genotype in acute exacerbation, HBeAg seroconversion, cirrhosis-related complications, and hepatocellular carcinoma.Hepatology. 2003 Mar;37(3):562-7. doi: 10.1053/jhep.2003.50098. Hepatology. 2003. PMID: 12601354
-
High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma.J Clin Oncol. 2008 Jan 10;26(2):177-82. doi: 10.1200/JCO.2007.13.2043. J Clin Oncol. 2008. PMID: 18182659
-
Natural history of chronic hepatitis B REVEALed.J Gastroenterol Hepatol. 2011 Apr;26(4):628-38. doi: 10.1111/j.1440-1746.2011.06695.x. J Gastroenterol Hepatol. 2011. PMID: 21323729 Review.
-
The clinical implications of hepatitis B virus genotype: Recent advances.J Gastroenterol Hepatol. 2011 Jan;26 Suppl 1:123-30. doi: 10.1111/j.1440-1746.2010.06541.x. J Gastroenterol Hepatol. 2011. PMID: 21199523 Review.
Cited by
-
Risk for hepatocellular carcinoma in the course of chronic hepatitis B virus infection and the protective effect of therapy with nucleos(t)ide analogues.World J Hepatol. 2015 May 18;7(8):1064-73. doi: 10.4254/wjh.v7.i8.1064. World J Hepatol. 2015. PMID: 26052395 Free PMC article. Review.
-
Hepatitis B and Hepatitis D Viruses: A Comprehensive Update with an Immunological Focus.Int J Mol Sci. 2022 Dec 15;23(24):15973. doi: 10.3390/ijms232415973. Int J Mol Sci. 2022. PMID: 36555623 Free PMC article. Review.
-
The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B.Hepatol Int. 2009 Jun;3(2):334-42. doi: 10.1007/s12072-008-9112-z. Epub 2008 Nov 26. Hepatol Int. 2009. PMID: 19669359 Free PMC article.
-
rt269I Type of Hepatitis B Virus (HBV) Leads to HBV e Antigen Negative Infections and Liver Disease Progression via Mitochondrial Stress Mediated Type I Interferon Production in Chronic Patients With Genotype C Infections.Front Immunol. 2019 Jul 24;10:1735. doi: 10.3389/fimmu.2019.01735. eCollection 2019. Front Immunol. 2019. PMID: 31402915 Free PMC article. Clinical Trial.
-
Novel machine learning models outperform risk scores in predicting hepatocellular carcinoma in patients with chronic viral hepatitis.JHEP Rep. 2022 Jan 22;4(3):100441. doi: 10.1016/j.jhepr.2022.100441. eCollection 2022 Mar. JHEP Rep. 2022. PMID: 35198928 Free PMC article.
References
-
- Beasley RP, Lin CC, Hwang LY, et al. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22707 men in Taiwan. Lancet 1981;ii:1129–32. - PubMed
-
- McMahon BJ, Holck P, Bulkow L, et al. Serologic and clinical outcomes of 1536 Alaska natives chronically infected with hepatitis B virus. Ann Intern Med 2001;135:759–68. - PubMed
-
- Liaw YF, Tai DI, Chu CM, et al. Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis. A prospective study. Gastroenterology 1986;90:263–7. - PubMed
-
- Sherman M , Peltekian KM, Lee C. Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population. Hepatology 1995;22:432–8. - PubMed
-
- McMahon BJ, Bulkow L, Harpster A, et al. Screening for hepatocellular carcinoma in Alsaka natives infected with chronic hepatitis B: A 16-year population-based study. Hepatology 2000;32:842–6. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical